PUBLICAE offers Tokenization of Political Attention by Empowering Citizens with Social & Economic Equity. Emancipation and enlightenment of the electorate increases voter turn-out and strengthens ethical-normative democratic principles. PUBLICAE ́s blockchain-based Ad-tech reward system is a public discourse, a dialectic exchange of conceptualised values which enables outreach efforts and organisational advertising strategies with rewarded audience targeting. Users can earn $STATE for their awareness as a token of appreciation by watching video ads from verified publishers like political parties, NGOs, educational institutions and faith based communities.

We are developing a new environmentally friendly technology to replace the existing high energy time-consuming procedure in the greenhouses, to help the farmers grow plants faster with better quality and less consumption of energy. Our treatment can be used to control plant size, quality, and speed of growth, and also to preserve plants for a long period.

In this industry, we are not required to disclose the content of the products we sell. There are no requirements for the production, process, or raw material before the products are sold. The vagina is the most absorbent organ you have. If the products you use contain potentially toxic chemicals, you may run the risk of getting them right into your bloodstream. With this in mind as well as an idea for more transparent and to-the-point marketing, the founder of Flove, Jeanett wanted to develop a well-documented menstrual cup, of high quality and without toxic chemicals. After 2,5 years of testing, prototyping, failing, and researching Flove menstrual cup finally launched in May 2019. The cups are designed and developed in Norway and are produced in a certified "clean room" in Taiwan. Jeanette visited the factory in March 2019. The silicone used is certified medical-grade silicone from Dow Corning. The bag coming with the menstrual cup when buying one is made of lyocell Tencel, printed and sewn at Fabrikk Oslo. The packaging is made of carton and is printed at 07 media in Oslo. The goal is to make menstrual cup mainstream and to sell more sustainable products. *  One of the reasons Flove was established was to help girls to stay in school around the world. There are so many girls who can't afford sanitary pads and the result is often that many girls drop out of school. We are looking for the right partner to help us help as many girls as possible to stay in school.

Tekhuset AS er et av Norges raskest voksende netthandelskonsern. Siden oppstarten i 2018 har selskapet på kort tid etablert seg som en trygg og spennende utfordrer innen netthandel i ulike produktkategorier. Norges største leverandør innenfor telefoni og nettbrett. Selger alt av reservedeler både B2C og B2B og er desidert størst i Norge innenfor dette området. Stort vekstpotensialet når det kommer til videreutvikling.

Ava was acquired by Motorola Solutions in 2022 and is now part of its portfolio. Ava is a global technology company with offices in the UK, Norway, and the USA. We exist because we believe that we can create a better, smarter way to deliver security. We help organizations see, understand, and act on their surroundings to protect their people, business, and reputation in real time.

The job search agent that works for you.

The Farm Society™ is a brand child of Plant Tech AS, born and bred in Trondheim. We deliver freshly harvested greens, herbs and gourmet mushrooms to restaurants, hotels, cantines and catering. Plant Tech explores and develops solutions for urban agriculture and indoor factory farming. We produce climate-friendly leafy vegetables and greens that are delivered at peak within hours after harvesting.

AVISOMO is developing indoor growing modules for farmers. These modules have an integrated regulation system that automatically cares for the environment inside and outside the module. The environment being nutrients in the hydroponic nutrient solution, pH levels, temperature, CO2 levels, light intensity and so on. This regulator is what makes this technology available to everyone. The regulation technology combined with top-shelf advanced LED makes our modules the best way to increase a farmer's yield more cost- and labour-effective.

The future of the internet is 3D, and people will increasingly create and express themselves in 3D. Sloyd is using automation to make the creation of 3D faster and more accessible and to make 3D rendering more efficient. We are building a simple-to-use WebApp to quickly generate 3D assets and a software development kit for performance-efficient runtime creation in video games and virtual worlds. Sloyd combines procedural generation techniques, machine learning, and a commitment to real-time optimization to provide the best 3D automation tools. Sloyd is a remote-first company and employees can work from home, a shared-space hub, or from the main office in Oslo. We don’t care where you come from, we only care about your passion and creativity.

The Founder Institute is the world’s premier startup launch program for talented entrepreneurs. If you are up to the challenge, our comprehensive step-by-step program will give you the structure, mentor support, and network of entrepreneurs you need to start an enduring company. Based in Silicon Valley and with chapters across 60 countries, the Founder Institute's mission is to "Globalize Silicon Valley" and build sustainable startup ecosystems worldwide.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Nanook is a global movement of more than 2400 local travel experts committed to sharing amazing experiences and insider knowledge. Being a partner of Nanook not only require high quality, but we also have non-negotiable rules of local ownership and responsibility towards nature and local communities.

Fishency Innovation can give access to the entire salmon industry to affordable equipment to count automatically sea lice in the cage. Monitoring sea lice is the key to controlling them, it is access to good decision support for optimized treatments and to a reliable tool to measure the efficiency of preventive measures and existing treatments. Today, sea lice are counted manually over 20 fish, every week, in each cage. It is labor-demanding, and the collected data are not reliable. Sustainability starts with good data.

Zegeba is a software company based in Ålesund, Norway! International enterprises and organizations use our innovative digital data solutions for time-saving and effective collaboration, reporting, and data capture. Zegeba is a unified digital solution for all types and sizes of forms, tasks, reports, inspections, multimedia, and data capture in general on apps, mobile, tablet, or web. Zegeba works both online and offline, and thereby empowers happy workers around the world every day! Zegeba Platform is built for easy transformation of human work processes related to documentation work on paper or files requiring manual rework, into an all-digital format that can be used as part of an automated process, and generates reports and data for analysis immediately. All businesses are unique and with Zegeba it is possible to create and design forms, tasks, checklists, and digital reports to suit your needs and core processes. Get control of data, save time, and increase the quality of your data using Zegeba.